mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.02 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
AZD1480 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
BRD-K90370028 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
NVP-BEZ235 |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.02 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.02 |